 |
BioWorld-Insight-2011-05-02
'Reality Bites': Licensing Trends Highlight Less Money, More Risk
'Reality Bites': Licensing Trends Highlight Less Money, More Risk
With venture capital getting hard to come by and the arrival of big pharma's dreaded patent cliff, "it seems like a perfect storm" for a burst of licensing and collaboration activity for the biotech sector, said Hemmie Chang, of Foley Hoag LLP's licensing & strategic alliance practice group.